Clinical Trials List
Protocol NumberQCR12009
2014-01-01 - 2016-12-31
Phase I
Terminated1
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Hao-Wei Teng Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- 藍耿立 Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Chi-Mu Chuang Division of Obstetrics & Gynecology
- Ta-Chung Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
27 participants
-
Global
27 participants
